Understanding HPV and Oral Cancer
About the Course
Understanding HPV and Oral Cancer is a daylong course dedicated to new research and advances in head and neck cancers caused by the human papillomavirus. In recent years, head and neck cancer patients have changed dramatically. Join us to discuss the latest in research and treatment on this emerging epidemic.
Keynote speaker Dr. Erich Sturgis (internationally recognized HPV epidemiology expert) to discuss increasing incidence of viral related cancers and their growing impact on the population.
Practice Gaps and Needs
Regionally, Understanding HPV and Oral Cancer intends to increase knowledge in diagnosis and treatments of oral cancers. Oral cancers due to HPV have rapidly increased in uncommon patient groups. Although, there is more research, patient survival rates have remained essentially unchanged over the past 30 years. This course will provide a comprehensive review of innovative research, cutting edge diagnostics, and best practices for treatment.
Elements of Competence
This CE activity has been designed to improve learner competence and focuses on the American Board of Medical Specialties’ areas of patient care and procedural skills, and medical knowledge.
This educational activity is designed to meet the needs of primary care physicians, medical otolaryngologists, oncologists, and other allied health personnel who treat and evaluate patients with head and neck cancers.
At the conclusion of this activity, participants will be able to:
- Provide primary care providers, dentists, otolaryngologists and oncologists with an update on the HPV induced oral cancer epidemic
- Identify demographics, risk factors, imaging hallmarks, and treatment options for HPV induced oral cancer.
- Show the impact of treatment on quality of life and efforts to de-escalate therapy to reduce toxicities.
- Explain the importance of vaccination in the prevention of HPV related malignancy in Wisconsin and beyond.
An Epidemic of Viral-related Cancers: HPV and Beyond
Speaking with Children and Families about the HPV Vaccine: A Pediatrician Perspective
Radiographic Features of HPV + Oropharyngeal Cancer
Questions and Discussion
The Role of Surgery: TORS and TLM
Treatment De-escalation Efforts: Summary of Clinical Trials
HPV Neck Node Cancer from Unknown H&N Primary
Role of Chemotherapy and Immunotherapy in HPV and SCCA
Questions and Discussion
HPV-related Oropharyngeal Cancer: Screening and Staging
Treatment Induced Dysphagia in HPV + SCCA
Multi-dimensional Bioinformatics Analysis of Head and Neck Cancers
Questions and Discussion
Head and Neck Tumor Board: Panel Discussion
Questions and Discussion
Casual attire is appropriate for this conference. Since meeting room temperatures and personal comfort levels vary, it is recommended that you bring a sweater or jacket to the educational activity.
A block of rooms has been reserved at the Wisconsin Union Hotel (1308 West Dayton Street, Madison, WI 53715), across the street from our conference site, The Wisconsin Institutes for Discovery. To receive the special rate of $160.00, call 608-263-2600 to make your reservation and mention Group Code "HNC2019" or Group Name "Head & Neck Course." The block of rooms will be held on a first-come, first-serve basis and any available rooms that have not been reserved by July 14, 2019, will be released to the general public. Complimentary parking for one car per room is included at Union South.
Nearby parking is available in lot 20, which is located across University Avenue from the Discovery Center and can be accessed from University Avenue.
Parking also is available in lot 17, which is behind Engineering Hall and Camp Randall Stadium and can be accessed via North Randall Avenue. Lot 80, the Union South underground parking garage, can be accessed from Dayton Street.
From 7 AM until 4:30 PM, visitor parking in lots 17, 20 and 80 costs $1 per 30 minutes for the first three hours and $1 per hour thereafter, up to a maximum of $15 per day. From 4:30 PM until midnight, visitor parking costs $1 per hour, up to a maximum of $5 per evening.
Prices and availability are subject to change. For more information, please contact Transportation Services.
Gregory Hartig, MD (Co-Chair); Professor of Surgery
Paul Harari, MD (Co-Chair); Professor of Human Oncology
Annie Sugar, PA-C; Physician Assistant of Surgery
Laura Bucci; Administration Division Otolaryngology-Head & Neck Surgery
Veronica Watson, MSOD; Outreach and Continuing Education Program Manager
Terese Bailey, BS; Senior Outreach Specialist
Christopher Britt, MD; Head and Neck Surgical Oncology Fellowship, Johns Hopkins, Baltimore, MD
Erich Sturgis, MD, MPH: Professor of Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX
Stuart Wong, MD; Professor of Neoplastic Diseases, Medical College of Wisconsin, Milwaukee, WI
University of Wisconsin Faculty
Greg Avey, MD; Assistant Professor of Radiology
Howard Bailey, MD; Professor of Medicine
Lindsay Geier, MD; Assistant Professor of Pediatrics
Anthony Gitter, PhD; Assistant Professor, Biostatistics and Medical Informatics
Tiffany Glazer, MD; Assistant Professor of Surgery
Paul Harari, MD; Professor of Human Oncology
Greg Hartig, MD; Professor of Surgery
Mala Mathur, MD; Associate Professor of Pediatrics
Aaron Wieland, MD; Assistant Professor of Surgery
Matthew Witek, MD; Assistant Professor of Human Oncology
Policy on Faculty and Sponsor Disclosure
It is the policy of the Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this educational activity, all conflicts of interest have been resolved and detailed disclosures are listed below:
|Name of Individual||Individual's Role in Activity||Name of Commercial Interest & Nature of Relationship||Discussion of|
uses of drugs/devices
|Greg Avey, MD||Presenter||No relevant financial relationships to diclose||No|
|Howard Bailey, MD||Welcome||No relevant financial relationships to disclose||No|
|Terese Bailey, BS||Planner||No relevant financial relationships to disclose||No|
|Christopher Britt, MD||Presenter||No relevant financial relationships to disclose||No|
|Laura Bucci||Planner||No relevant financial relationships to disclose||No|
|Lindsay Geier, MD||Presenter||No relevant financial relationships to disclose||No|
|Anthony Gitter, PhD||Presenter||No relevant financial relationships to disclose||No|
|Tiffany Glazer, MD||Presenter||No relevant financial relationships to disclose||Yes|
|Paul Harari, MD||Planner & Educational Reviewer||No relevant financial relationships to disclose||No|
|Gregory Hartig, MD||Planner & Educational Reviewer||No relevant financial relationships to disclose||No|
|Mala Mathur, MD, MPH||Presenter||AstraZeneca (Consultant); Spouse is Founder of Respiratory|
Monitoring (Stockholder or Other Ownership Interest Holder)
|Erich Sturgis, MD, MPH||Presenter||Roche Diagnostics (Research Awardee)||No|
|Annie Sugar, PA-C||Planner||No relevant financial relationships to disclose||No|
|Veronica Watson, BS, MA, MSOD||Planner||No relevant financial relationships to disclose||No|
|Aaron Wieland, MD||Presenter||No relevant financial relationships to disclose||No|
|Matthew Witek, MD||Presenter||Sanofi Genzyme (Consultant and Member of Advisory Committee|
or Review Panel)
|Stuart Wong, MD||Presenter||No relevant financial relationships to disclose||Yes|
*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
CREDIT DESIGNATION STATEMENTS
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units (CEUs)
The University of Wisconsin–Madison, as a member of the University Professional Continuing Education Association (UPCEA), authorizes this program for 0.50 continuing education units (CEUs) or 5.0 hours.
- 5.00 AMA PRA Category 1 Credit™
- 5.00 University of Wisconsin–Madison Continuing Education Hours
Syllabus & Conference Materials
Conference materials will be available to registered participants 48 hours prior to the event at this conference site.
CANCELLATION AND REFUND POLICY
Requests for cancellation must be submitted in writing to firstname.lastname@example.org. Cancellation requests received at least 96 hours prior to the conference will allow a full refund except for the $50 nonrefundable processing fee. No refunds will be made for cancellations received less than 96 hours prior to the activity start date.
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
FOR FURTHER INFORMATION
For conference information or details regarding exhibit booths, please contact Veronica Watson at 608-263-7697 or email@example.com.